2nd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$171,340
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); White House Office; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Food & Drug Administration (FDA); SENATE; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); White House Office; HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO)

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Office of Management & Budget (OMB); White House Office; Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA)

Health Issues HCR

Medicare Physician Payments Reform. Patient access to care; Graduate Medical Education. Physician Workforce Issues. Health reform implementation (PL 111-148). Telehealth (Health Information Technology). See continuation page.S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013. H.R. 2810, SGR Repeal and Medicare Beneficiary Access Act of 2013. Pathway for SGR Reform Act of 2013.

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
ANGELA JEANSONNE —
CAROL MONACO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Food & Drug Administration (FDA); Office of Management & Budget (OMB); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); White House Office; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO)

Bills named: H.R. 2810 (113th), S. 1871 (113th)

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013. See continuation page.S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013. H.R. 2810, SGR Repeal and Medicare Beneficiary Access Act of 2013. Pathway for SGR Reform Act of 2013.

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
ANGELA JEANSONNE —
CAROL MONACO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Government Accountability Office (GAO); Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); White House Office; HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP)

Bills named: H.R. 2810 (113th), S. 1871 (113th), H.R. 574 (113th)

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); White House Office; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ); SENATE

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplaces

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); White House Office

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
ANGELA JEANSONNE —
CAROL MONACO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: White House Office; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.